Maximus Earns URAC Accreditation for Health Utilization Management in Clinical ReviewsBusiness Wire • 12/04/24
Down -16.15% in 4 Weeks, Here's Why Maximus (MMS) Looks Ripe for a TurnaroundZacks Investment Research • 11/25/24
Curious about Maximus (MMS) Q4 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 11/15/24
Efficient Receivables Management Aids Maximus Amid Declining IncomeZacks Investment Research • 09/18/24
Compared to Estimates, Maximus (MMS) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 08/08/24
Countdown to Maximus (MMS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 08/06/24